Mental Health in Eosinophilic Gastrointestinal Disorders: A Work Group Report of the AAAAI Eosinophilic Gastrointestinal Disorders Committee

IF 7.2 1区医学 Q1 ALLERGY

Journal of Allergy and Clinical Immunology-In Practice Pub Date : 2026-10-01 Epub Date: 2026-10-07 DOI:10.1016/j.jaip.2026.06.047

Anupama Kewalramani MD, Gregory M. Constantine MD, Brandi Whitaker PhD, Mirna Chehade MD, MPH, Elizabeth T. Jensen MPH, PhD, Benjamin L. Wright MD, Peter Capucillig MD, Russell Hopp DO, Barry Pelz MD, Taha Al-Shaikhly MBChB, Robert Pesek MD

{"title":"Mental Health in Eosinophilic Gastrointestinal Disorders: A Work Group Report of the AAAAI Eosinophilic Gastrointestinal Disorders Committee","authors":"Anupama Kewalramani MD, Gregory M. Constantine MD, Brandi Whitaker PhD, Mirna Chehade MD, MPH, Elizabeth T. Jensen MPH, PhD, Benjamin L. Wright MD, Peter Capucillig MD, Russell Hopp DO, Barry Pelz MD, Taha Al-Shaikhly MBChB, Robert Pesek MD","doi":"10.1016/j.jaip.2026.06.047","DOIUrl":null,"url":null,"abstract":"<div><div>Psychiatric comorbidities, including anxiety and depression, are increased in individuals with eosinophilic gastrointestinal disorder (EGID) compared with the general population. However, there are no established guidelines for screening and evaluating mental health disorders, and screening practices are unclear. We e-mailed an anonymous Web-based survey to members of the American Academy of Allergy, Asthma & Immunology and the Consortium of Eosinophilic Gastrointestinal Disease Researchers to examine mental health screening practices among clinicians caring for patients with EGIDs in the United States. Literature examining the association between mental health disorders and EGID was reviewed, best practices for anxiety and depression screening were discussed, and recommendations for implementing successful screening programs were formulated. Most survey respondents (62%; n = 31 of 50) indicated screening for anxiety and depression was important; however, only 18.6% (n = 11 of 59) conducted screening as part of standard clinical care for these patients. The most cited barriers to screening included a lack of time, limited expertise, and inadequate screening resources. This report provides recommendations and resources to facilitate the implementation of anxiety and depression screening in patients with EGIDs.</div></div>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":"14 10","pages":"Pages 2244-2253"},"PeriodicalIF":7.2000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213219826006823","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Psychiatric comorbidities, including anxiety and depression, are increased in individuals with eosinophilic gastrointestinal disorder (EGID) compared with the general population. However, there are no established guidelines for screening and evaluating mental health disorders, and screening practices are unclear. We e-mailed an anonymous Web-based survey to members of the American Academy of Allergy, Asthma & Immunology and the Consortium of Eosinophilic Gastrointestinal Disease Researchers to examine mental health screening practices among clinicians caring for patients with EGIDs in the United States. Literature examining the association between mental health disorders and EGID was reviewed, best practices for anxiety and depression screening were discussed, and recommendations for implementing successful screening programs were formulated. Most survey respondents (62%; n = 31 of 50) indicated screening for anxiety and depression was important; however, only 18.6% (n = 11 of 59) conducted screening as part of standard clinical care for these patients. The most cited barriers to screening included a lack of time, limited expertise, and inadequate screening resources. This report provides recommendations and resources to facilitate the implementation of anxiety and depression screening in patients with EGIDs.

查看原文本刊更多论文

嗜酸性粒细胞胃肠道疾病的心理健康：AAAAI嗜酸性粒细胞胃肠道疾病委员会的工作组报告

与普通人群相比，嗜酸性胃肠道疾病（EGID）患者的精神合并症（包括焦虑和抑郁）增加。然而，目前还没有确定的筛查和评估精神健康障碍的指导方针，筛查的做法也不清楚。我们通过电子邮件向美国过敏、哮喘与免疫学学会和嗜酸性胃肠道疾病研究联盟的成员发送了一份匿名的网络调查，以检查美国治疗egid患者的临床医生的心理健康筛查做法。本文回顾了研究心理健康障碍与EGID之间关系的文献，讨论了焦虑和抑郁筛查的最佳做法，并制定了实施成功筛查计划的建议。大多数受访者（62%,n = 31 / 50）表示焦虑和抑郁筛查很重要；然而，只有18.6% （n = 11 / 59）将筛查作为这些患者标准临床护理的一部分。最常见的筛查障碍包括缺乏时间、专业知识有限和筛查资源不足。本报告提供建议和资源，以促进在egid患者中实施焦虑和抑郁筛查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Allergy and Clinical Immunology-In Practice ALLERGYIMMUNOLOGY-IMMUNOLOGY

CiteScore

11.10

自引率

9.60%

发文量

683

审稿时长

50 days

期刊介绍： JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases. This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders. The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.